Multimetabolic 18F-Fluorodeoxyglucose (FDG) and 18F-Fluorocholine (FCH) Positron Emission Tomography (PET) as an Early Predictive Factor of Overall Survival in Patients With Advanced Hepatocellular Carcinoma Treated With Sorafenib
Clinical trial NCT02847468 · TERMINATED
Trial details
- NCT number
- NCT02847468
- Sponsor
- Centre Georges Francois Leclerc
- Status
- TERMINATED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-27
- Primary completion
- 2021-12-23
- Enrollment
- 61
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.